Mezigdomide,Bortezomib,Dexamethasone,Daratumumab,Carfilzomib,Elotuzumab,Isatuximab
BMS,Takeda,Janssen,Amgen,Sanofi
['220,mm,001', ' sun ', 'nct03989414', 'mmsm', 'mezigdomide', 'mm-001', ' pom ', 'cc-92480', 'lymphoma', 'dexamethasone', 'multiple myeloma', 'cc,220,mm,001', 'borte', 'celmod', 'emergent ', 'noria ', 'celgene']
mezi the new name for mezigdomide .significant responses in imid refractory patients 54%grade 4 neutropenia major adverse effect good responses in heavily pretreated patients #ash22 #mmsm 
passionate about Haematology, improving outcomes for myeloma patients. Also cycle +live in the most beautiful part of England and the best city in the world ...